Altai Capital Management, L.P. recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
152 West 57th Street, 10th Floor New York, NY 10019
As of the latest 13F report, the guru’s equity portfolio contained 5 stocks valued at a total of $108.00Mil. The top holdings were DMRC(49.32%), OSPN(23.84%), and ETWO(13.80%).
According to GuruFocus data, these were Altai Capital Management, L.P.’s top five trades of the quarter.
P10 Inc
The guru sold out of their 1,152,400-share investment in NYSE:PX. Previously, the stock had a 11.92% weight in the equity portfolio. Shares traded for an average price of $10.35 during the quarter.
On 02/17/2023, P10 Inc traded for a price of $11.5 per share and a market cap of $1.35Bil. The stock has returned -11.19% over the past year.
GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 5 out of 10.
In terms of valuation, P10 Inc has a price-earnings ratio of 54.25, a price-book ratio of 3.31, a EV-to-Ebitda ratio of 24.11 and a price-sales ratio of 7.45.
E2open Parent Holdings Inc
Altai Capital Management, L.P. reduced their investment in NYSE:ETWO by 674,823 shares. The trade had a 4.03% impact on the equity portfolio. During the quarter, the stock traded for an average price of $5.73.
On 02/17/2023, E2open Parent Holdings Inc traded for a price of $6.27 per share and a market cap of $1.90Bil. The stock has returned -30.33% over the past year.
GuruFocus gives the company a financial strength rating of 4 out of 10 and a profitability rating of 2 out of 10.
In terms of valuation, E2open Parent Holdings Inc has a price-book ratio of 0.69, a EV-to-Ebitda ratio of -13.51 and a price-sales ratio of 3.04.
OneSpan Inc
During the quarter, Altai Capital Management, L.P. bought 361,247 shares of NAS:OSPN for a total holding of 2,300,000. The trade had a 3.74% impact on the equity portfolio. During the quarter, the stock traded for an average price of $11.49.
On 02/17/2023, OneSpan Inc traded for a price of $13.89 per share and a market cap of $550.91Mil. The stock has returned -14.62% over the past year.
GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 6 out of 10.
In terms of valuation, OneSpan Inc has a price-book ratio of 2.82, a EV-to-Ebitda ratio of -31.60 and a price-sales ratio of 2.50.
The price-to-GF Value ratio is 0.79, earning the stock a GF Value rank of 9.
Sunlight Financial Holdings Inc
The guru sold out of their 396,000-share investment in NYSE:SUNL. Previously, the stock had a 0.48% weight in the equity portfolio. Shares traded for an average price of $1.38 during the quarter.
On 02/17/2023, Sunlight Financial Holdings Inc traded for a price of $1.55 per share and a market cap of $127.14Mil. The stock has returned -53.92% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 5 out of 10.
In terms of valuation, Sunlight Financial Holdings Inc has a price-book ratio of 0.45, a EV-to-Ebitda ratio of -0.13 and a price-sales ratio of 1.02.
Pardes Biosciences Inc
The guru sold out of their 82,097-share investment in NAS:PRDS. Previously, the stock had a 0.15% weight in the equity portfolio. Shares traded for an average price of $1.27 during the quarter.
On 02/17/2023, Pardes Biosciences Inc traded for a price of $1.72 per share and a market cap of $106.18Mil. The stock has returned -79.93% over the past year.
GuruFocus gives the company a financial strength rating of 8 out of 10 and a profitability rating of 1 out of 10.
In terms of valuation, Pardes Biosciences Inc has a price-book ratio of 0.53 and a EV-to-Ebitda ratio of 1.20.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
